Retension Pharmaceuticals, Inc.
RTSN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002002988
In the last 90 days, Retension Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysLast 90 days, $369.6K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding RTSN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding RTSN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Retension Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 (view filing)6:12 PM ET | Oct 13 | Same day | Keller Eric L.CHIEF EXECUTIVE OFFICER | PPurchase | +20.8K | $12.00 | +$249.6K | +5.2%423.4K after | |
| Oct 13, 2026 (view filing)6:10 PM ET | Oct 13 | Same day | Berger Franklin MDirector | PPurchase | +10.0K | $12.00 | +$120.0K | New position10.0K after |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in Retension Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding RTSN in 13F filings for Q2 2026.
Holders of 5% or more of RTSN
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Retension Pharmaceuticals, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| B Group, Inc. | 13G | 10.00%833.3K shares | New | Oct 16, 20261 filing | Oct 16, 2026 | SEC |
| PVG Asset Management Corp | 13G | 8.30%1.00M shares | New | Oct 16, 20261 filing | Oct 16, 2026 | SEC |
| Lytton Laurence W | 13G | 7.40%617.2K shares | New | Oct 15, 20261 filing | Oct 15, 2026 | SEC |
| Keller Eric L. | 13D | 7.07%598.6K shares | New | Oct 14, 20261 filing | Oct 14, 2026 | SEC |